Maravai LifeSciences (MRVI) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
August 4, 2022 4:51 PM EDTSAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, August 4th, by Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), please note that a variety of changes have been made throughout the release. These includes the wording of the subheadline, the wording and figure in the fourth bullet point,  the wording and figures in the last paragraphs of each Financial Results section, and the Explanatory Notes numbers (9) and (10). The corrected release follows:
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
... More